Table 3.
Variables | Baseline moderate to severe RVSPa | Mortality rate at 6 months | ||||
---|---|---|---|---|---|---|
aOR, 95%CI | P value | HIV-unadjustedb | HIV-adjustedc | |||
aHR, 95%CI | P value | aHR, 95%CI | P value | |||
Use of biomass fuel | 3.07, 1.02–9.28 | 0.046 | ||||
Unknown HIV status | 2.73, 0.96–7.73 | 0.07 | ||||
NYHA FC III/IV | 4.18, 1.01–17.38 | 0.049 | 4.2, 0.96–18.47 | 0.058 | 5.03, 1.53–16.51 | 0.008 |
RVSP (mmHg) | 1.07, 1.03–1.11 | 0.001 | 1.08, 1.02–1.13 | 0.004 | ||
IVSS | 1.25, 1.07–1.46 | 0.005 | 1.2, 1.00–1.43 | 0.051 | ||
BMI (kg/m2) | 0.75, 0.8–0.98 | 0.034 | 0.77, 0.59–1.00 | 0.05 | ||
Alcohol abuse | 4.77, 0.60–37.97 | 0.14 | 7.14, 1.04–49.07 | 0.046 |
RVSP: right ventricular systolic pressure, NYHA/FC: New York Heart Association Functional Classification, BMI: Body Mass Index, IVSS: interventricular septum systolic, TAPSE: tricuspid annular plane systolic excursion.
aModel adjusted for sex, age, occupation type, diabetes, hypertension, exposure to schistosomiasis, alcohol abuse, rheumatic diseases, peripheral oedema, and 6 min walking distance.
bModel adjusted for age, sex, smoking habit, left atrial size, TAPSE, pulse at rest, hypercholesterolemia, alcohol abuse and ejection fraction calculated (EF).